TRIM31 and inflammatory bowel disease: In DSS-induced murine models, TRIM31 was found to enhance the ubiquitin–proteasome pathway of the NLRP3 inflammasome in macrophages, which are linked to IBD pathogenesis, and it downregulates intestinal inflammation by inducing autophagy in CD [42].